AZD4017 and prednisolone ( DrugBank: Prednisolone, AZD-4017 )


1 disease
IDDisease name (Link within this page)Number of trials
75Cushing disease1

75. Cushing disease


Clinical trials : 203 Drugs : 191 - (DrugBank : 51) / Drug target genes : 62 - Drug target pathways : 128
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03111810
(ClinicalTrials.gov)
May 25, 201717/3/2017Targeting Iatrogenic Cushing's Syndrome With 11ß-hydroxysteroid Dehydrogenase Type 1 InhibitionTargeting Iatrogenic Cushing's Syndrome With 11ß-hydroxysteroid Dehydrogenase Type 1 Inhibition (TICSI)Iatrogenic Cushing's DiseaseDrug: AZD4017 and prednisolone;Drug: Placebo Oral Tablet and prednisoloneUniversity of OxfordAstraZenecaCompleted18 Years60 YearsMale32Phase 2United Kingdom